The Department of Radiation Oncology at UCI has finalized an agreement with ViewRay, Inc. to bring the latest magnetic resonance imaging (MRI)-based linear accelerator to Irvine. The ViewRay device, which first gained FDA approval in 2014, offers the ability to treat hard-to-reach tumors with a high level of precision and accuracy. It is anticipated that clinical trials will be rolled out after this technology is implemented. To read more, please click here: (https://www.prnewswire.com/news-releases/uci-health-adopts-viewray-mridian-mri-guided-radiation-therapy-system-301538142.html)